HR+ Metastatic Breast Cancer

EP. 1: Managing Recurrent Metastatic ER+/HER2- Breast Cancer

April 18th 2019

EP. 2: CDK4/6 Inhibitors & Endocrine Therapy in Breast Cancer

April 18th 2019

EP. 3: CDK4/6 Inhibitors & Endocrine Therapy: Selecting a Regimen

April 18th 2019

EP. 4: CDK4/6 Inhibitors & Endocrine Therapy: Adverse Events

April 18th 2019

EP. 5: CDK4/6 Inhibitors & Endocrine Therapy: Treatment Resistance

April 18th 2019

Trending on Targeted Onc

FDA Approves Amivantamab and Hyaluronidase for Recurrent/Metastatic HNSCC

Zocilurtatug Pelitecan Shows Activity in epNEC Across DLL3 Expression Levels

LITESPARK-011 Raises Questions About RCC Treatment Sequencing

Dr Mohamed on Zocilurtatug Pelitecan for Refractory Extrapulmonary NEC

COA Backs 340B Payment Cut in 2027 Final Rules, Warns of Physician Cuts